Clinical Trials Logo

Clinical Trial Summary

Endobronchial ultrasound (EBUS) multimodal image including grey scale, blood flow doppler and elastography, can be used as non-invasive diagnosis and supplement the pathological result, which has important clinical application value. In this study, EBUS multimodal image database of 1000 inthoracic benign and malignant lymph nodes (LNs) will be constructed to train deep learning neural networks, which can automatically select representative images and diagnose LNs. Investigators will establish an artificial intelligence prediction model based on deep learning of intrathoracic LNs, and verify the model in other 300 LNs.


Clinical Trial Description

Intrathoracic LNs enlargement has a wide range of diseases, among which intrathoracic LNs metastasis of lung cancer is the most common malignant disease. Benign lesions, including inflammation, tuberculosis and sarcoidosis, also need to be differentiated for targeted treatment.

EBUS multimodal image including grey scale, blood flow doppler and elastography, can be used as non-invasive diagnosis and supplement the pathological result, which has important clinical application value. This study includes two parts: retrospectively construction of EBUS artificial intelligence prediction model and multi-center prospectively validation of the prediction model. A total of 1300 LNs will be enrolled in the study.

During the retention of videos, target LNs and peripheral vessels are examined using ultrasound hosts (EU-ME2, Olympus or Hi-vision Avius, Hitachi) equipped with elastography and doppler functions and ultrasound bronchoscopy (BF-UC260FW, Olympus or EB1970UK, Pentax). Multimodal image data of target LNs are collected.

Investigators will construct artificial intelligence prediction model based on deep learning using images from 1000 LNs firstly, and verify the model in other 300 LNs. This model will be compared with traditional qualitative and quantitative evaluation methods to verify the diagnostic efficacy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04328792
Study type Observational
Source Shanghai Chest Hospital
Contact Jiayuan Sun, MD, PhD
Phone 86-21-22200000
Email jysun1976@163.com
Status Recruiting
Phase
Start date July 1, 2018
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03903471 - 22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA N/A
Recruiting NCT04456283 - Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy
Recruiting NCT06340620 - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A
Completed NCT00287196 - Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes Phase 3
Terminated NCT03073096 - LYMPHA: Eliminating the Burden of Lymphedema in Patients Requiring Nodal Dissection N/A
Recruiting NCT03621852 - Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)
Not yet recruiting NCT06049758 - D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy N/A
Recruiting NCT04403867 - The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Completed NCT04497714 - Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study
Completed NCT06243965 - Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?
Completed NCT04735302 - Radiographic Characteristics of Mediastinal and Hilar Lymph Nodes in Sarcoidosis
Completed NCT03132883 - Evolution of Indications for Transbronchial Ganglionic Ultrasound
Completed NCT02998619 - Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis
Not yet recruiting NCT03760094 - Role of Color Doppler Ultrasound in Lymphadenopathy N/A
Terminated NCT03204994 - Fluorescence Targeted Pelvic Lymph Node Mapping Phase 1/Phase 2